By Jarek Rutz (October 30, 2025, 7:06 p.m. EDT) — Johnson & Johnson's Janssen Products LP urged the Third Circuit to overturn a $1.6 billion False Claims Act judgment related to two of its HIV drugs, arguing that the district court allowed whistleblowers to prove fraud based solely on “off-label” marketing rather than any false claims actually submitted to the government….
Law360 is there, so you are too.
A Law360 subscription puts you at the center of rapidly evolving legal issues, trends and developments so you can act with speed and confidence. More than 200 articles are published daily on more than 60 topics, sectors, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge Information
- Real-time alerts
- More than 450,000 archived articles available for consultation
And much more!
Check out Law360 today with a 7-day free trial.
